MTOR and neoplasm: We have previously tested several inhibitors of the PI3K/Akt (LY294002 and wortmannin) and mTOR (rapamycin) pathways or both (PI-103)[14], by using 3D mesothelioma models grown from cell lines (multicellular spheroids) and actual tumor (tumor fragment spheroids) [1, 2].